PL3920890T3 - Doustna tabletka kannabinoidowa - Google Patents
Doustna tabletka kannabinoidowaInfo
- Publication number
- PL3920890T3 PL3920890T3 PL20726699.0T PL20726699T PL3920890T3 PL 3920890 T3 PL3920890 T3 PL 3920890T3 PL 20726699 T PL20726699 T PL 20726699T PL 3920890 T3 PL3920890 T3 PL 3920890T3
- Authority
- PL
- Poland
- Prior art keywords
- oral cannabinoid
- tablet
- cannabinoid tablet
- oral
- cannabinoid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/148—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA3040513A CA3040513C (en) | 2019-04-17 | 2019-04-17 | An oral cannabinoid tablet |
| US16/386,477 US10925853B2 (en) | 2019-04-17 | 2019-04-17 | Oral cannabinoid tablet |
| PCT/DK2020/050100 WO2020211913A1 (en) | 2019-04-17 | 2020-04-17 | An oral cannabinoid tablet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3920890T3 true PL3920890T3 (pl) | 2024-03-18 |
Family
ID=70775241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20726699.0T PL3920890T3 (pl) | 2019-04-17 | 2020-04-17 | Doustna tabletka kannabinoidowa |
Country Status (8)
| Country | Link |
|---|---|
| EP (2) | EP4289423A3 (pl) |
| CN (1) | CN113710235B (pl) |
| AU (1) | AU2020259627B2 (pl) |
| DK (1) | DK3920890T3 (pl) |
| ES (1) | ES2966539T3 (pl) |
| FI (1) | FI3920890T3 (pl) |
| PL (1) | PL3920890T3 (pl) |
| WO (1) | WO2020211913A1 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11096894B2 (en) | 2018-05-17 | 2021-08-24 | Fertin Pharma A/S | Oral tablet for induced saliva generation |
| US11633351B2 (en) * | 2019-12-13 | 2023-04-25 | Nordiccan A/S | Fast disintegrating cannabinoid tablets |
| JP2024512417A (ja) * | 2021-03-12 | 2024-03-19 | ニコベンチャーズ トレーディング リミテッド | 自己乳化系を含む経口製品 |
| US20240008514A1 (en) | 2022-07-05 | 2024-01-11 | Fertin Pharma A/S | Cannabinoid Lipid Premixture |
| JP2025520956A (ja) * | 2022-07-05 | 2025-07-03 | フェルティン ファルマ アー/エス | カンナビノイド脂質予混合物 |
| US20260224493A1 (en) * | 2023-01-27 | 2026-08-06 | Fertin Pharma A/S | An Adhesive Oral Disc For Sustained Release Of Cannabinoids |
| US20260224480A1 (en) * | 2023-01-27 | 2026-08-06 | Philip Morris Products S.A. | System for oral delivery of an active ingredient |
| WO2025032115A1 (en) * | 2023-08-08 | 2025-02-13 | Avextra Portugal Sa | Cannabinoid granule composition |
| DK202330231A1 (en) * | 2023-09-27 | 2025-04-10 | Fertin Pharma As | Cannabidiol for alleviating xerostomia |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2609912A1 (en) * | 2011-12-30 | 2013-07-03 | Deva Holding Anonim Sirketi | Pharmaceutical combination of fingolimod and nabiximols |
| CA2992923C (en) * | 2014-07-21 | 2021-06-29 | Pharmaceutical Productions, Inc. | Solid dosage form composition for buccal and sublingual administration of cannabinoids |
| US10765658B2 (en) * | 2016-06-22 | 2020-09-08 | Mastix LLC | Oral compositions delivering therapeutically effective amounts of cannabinoids |
| CA3052564A1 (en) * | 2017-02-05 | 2018-08-09 | CannTab Therapeutics Limited | Flash-melt cannabinoid formulations |
| US10772837B2 (en) * | 2017-03-16 | 2020-09-15 | CannTab Therapeutics, Ltd | Modified release multi-layer tablet cannabinoid formulations |
-
2020
- 2020-04-17 PL PL20726699.0T patent/PL3920890T3/pl unknown
- 2020-04-17 AU AU2020259627A patent/AU2020259627B2/en active Active
- 2020-04-17 EP EP23204541.9A patent/EP4289423A3/en active Pending
- 2020-04-17 EP EP20726699.0A patent/EP3920890B1/en active Active
- 2020-04-17 FI FIEP20726699.0T patent/FI3920890T3/fi active
- 2020-04-17 CN CN202080029324.1A patent/CN113710235B/zh active Active
- 2020-04-17 DK DK20726699.0T patent/DK3920890T3/da active
- 2020-04-17 ES ES20726699T patent/ES2966539T3/es active Active
- 2020-04-17 WO PCT/DK2020/050100 patent/WO2020211913A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CN113710235B (zh) | 2024-03-29 |
| EP4289423A3 (en) | 2024-02-21 |
| AU2020259627B2 (en) | 2023-09-21 |
| EP3920890A1 (en) | 2021-12-15 |
| FI3920890T3 (fi) | 2023-11-30 |
| DK3920890T3 (da) | 2023-11-27 |
| ES2966539T3 (es) | 2024-04-22 |
| AU2020259627A1 (en) | 2021-10-28 |
| CN113710235A (zh) | 2021-11-26 |
| EP3920890B1 (en) | 2023-11-01 |
| WO2020211913A1 (en) | 2020-10-22 |
| EP4289423A2 (en) | 2023-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288423A (en) | Cannabinoid formulations | |
| EP3994692C0 (en) | BINARY COMPUTING CELL IN MEMORY | |
| DK3920890T3 (da) | Oral cannabinoid-tablet | |
| IL292161A (en) | New methylquinazolinone derivatives | |
| DK3935068T3 (da) | Abirateron-prodrugs | |
| EP4007967A4 (en) | Multiply-accumulate unit | |
| EP3997095C0 (en) | CANNABINOID DERIVATIVES | |
| EP3930851A4 (en) | COMBINATION THERAPIES | |
| EP3919491C0 (en) | AKT INHIBITOR | |
| EP3742771C0 (en) | M2M SM-SR TO SM-DP NOTIFICATION | |
| IL288173A (en) | Sonosensitization | |
| EP3967649C0 (en) | LIPID NANOPARTICLE | |
| EP3998174A4 (en) | SEAT | |
| EP4065549A4 (en) | Cannabinoid derivatives | |
| EP3973348A4 (en) | HEAD MOUNT DISPLAYS | |
| EP3912517C0 (en) | FRAME | |
| EP3957391C0 (en) | AGITATOR | |
| EP3975220A4 (en) | Display panel | |
| EP3962498A4 (en) | Combination therapies | |
| EP4032513A4 (en) | MOUTHPIECE | |
| EP4005489A4 (en) | Stethoscope | |
| EP3965638C0 (en) | VAGINAL SPECULUM | |
| DK3738452T3 (da) | Fordamper | |
| EP3682831C0 (en) | CRYOGENIC APPLICATOR | |
| PL3965739T3 (pl) | Postacie dawkowane będące tabletkami oleilofosfocholiny |